A voluntary national research platform that brings together information about adults living with Multiple Myeloma (MM) and related blood conditions across the Republic of Ireland

What is a clinical registry?

A clinical registry brings together health information from a group of people living with the
same condition. By collecting information in a consistent and standardised manner, we can
follow how a condition evolves over time and study disease patterns and outcomes in this
given condition. This type of information is called real-world data (RWD) and allows
researchers to build a broader picture of how a condition is managed and how people respond
to treatment. 

 

Why a registry for Multiple Myeloma (MM)

Multiple Myeloma is a complex disease that can behave differently from one person to another,
meaning that each person can experience a different disease journey. People may receive
different treatments and experience different responses to treatments, as well as periods of
remission, progression or relapse. 

 

The Multiple Myeloma Registry

This Registry aims to establish a national, long-term platform to collect and bring together
valuable clinical information on diagnosis, disease characteristics, treatments, treatments
response and outcomes from participants across the Republic of Ireland. By building this
resource, it can overtime support clinical and translational research for a better understanding
of MM and ultimately support care. 

 

Our video explaining about how the registry works

 

 

 

How does the Registry Work?

1. DISCOVER

Find out about the registry through our online information and resources

2. REGISTER INTEREST

Check eligibility and provide contact details if you require more information

3. CONSENT OPTIONS

Choose to give consent online or request a paper consent form sent to you

4. INCLUSION

A unique registry ID is attributed to you and relevant clinical data will be collected

5. LONGITUDINAL FOLLOW-UP

Your clinical information will be updated over time to better understand
responses and progression